INDIA IPO
  • Home
  • About
    • About us
    • Our CSR
  • Services

    IPO

    • Initial Public Offering (IPO)
    • SME IPO Consultation
    • Mainline IPO Consultation
    • Follow-On Public Offer (FPO)
    • Pre-IPO Funding Consultants

    Capital Raising

    • Social Stock Exchange
    • Private Placement
    • Project Funding
    • REIT
    • SM REIT
    • Rights Issue Advisory
    • InvIT Rights Issue
    • InvIT Public Issue
    • InvIT Private Issue
    • Debt Syndication
    • Securitised Debt Instruments
    • Public Municipal Debt
    • Private Municipal Debt

    Finance Advisory

    • Business Valuation
    • Corporate Finance
    • Financial Modelling
    • Project Finance
  • Investors
  • Merchant Bankers

    SME

    • List of SME Merchant Bankers

    MAINBOARD

    • List of Mainboard Merchant Bankers
  • Resources

    Reports

    • Daily Reporter
    • IPO Calendar
    • Mainline IPO Report
    • SME IPO Report
    • SME IPOs by Sector
    • Mainboard IPOs by Sector

    IPO Knowledge

    • IPO World Magazine
    • IPO Process
    • Pre-IPO Process Guidance
    • IPO Blogs
    • Sector Wise IPO List In India
    • List of IPO Registrar

    Notifications / Circulars

    • BSE SME Eligibility Criteria
    • SEBI ICDR Amendment Regulations March 2025
    • SEBI SME IPO ICDR Amendments report Mar–Nov 2025
    • NSE Emerge Eligibility Criteria
    • ICDR
  • News/Updates
    • Markets & Money Update
    • IPO & Market Snaps
  • Contact Us
  • Check IPO Feasibility
Check IPO Feasibility
INDIA IPO
INDIA IPO

Contact Info:

  • +91-96506-37280
  • +011-47008280
  • info@indiaipo.in
  • 808, 8thFloor D-Mall, Netaji Subhash Place, Pitampura, Delhi-110034.
shape
  1. Home
  2. News
  3. Biogen Pharmachem Industries Sets Record Date for 1:6 Bonus Share Issuance
ipo services in India
India IPO
  • 01 Apr 2026
  • X
 Biogen Pharmachem Industries Sets Record Date for 1:6 Bonus Share Issuance

Biogen Pharmachem Industries Limited has set May 15, 2026, as the record date for its 1:6 bonus share issuance, where shareholders will receive 1 new equity share of Rs.1/- for every 6 existing shares. The proposal requires shareholder approval via postal ballot and e-voting, with the company maintaining full regulatory compliance under SEBI LODR requirements.

Biogen Pharmachem Industries Sets Record Date for 1:6 Bonus Share Issuance

Biogen Pharmachem Industries Limited has announced the record date for its upcoming bonus share issuance, marking a significant corporate action for existing shareholders. The company has set Friday, May 15, 2026, as the crucial date for determining shareholder eligibility for the proposed bonus equity shares.

Bonus Share Details

The company has proposed issuing bonus shares in an attractive 1:6 ratio, providing substantial value to existing shareholders. Under this arrangement, eligible shareholders will receive 1 new equity share of Rs.1/- each for every 6 existing equity shares of Rs.1/- each that are fully paid up.

Parameter: Details Record Date: Friday, May 15, 2026 Bonus Ratio: 1:6 New Share Value: Rs.1/- each Existing Share Value: Rs.1/- each Share Status: Fully paid up

Regulatory Compliance

The announcement has been made in compliance with Regulation 42 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has formally communicated this information to BSE Limited, where its shares are listed under scrip code 531752 and scrip ID BIOGEN.

Shareholder Approval Process

The bonus share issuance remains subject to shareholder approval, which the company is obtaining through postal ballot including e-voting facilities. This process ensures compliance with applicable laws and regulations while providing convenient voting options for shareholders.

Corporate Communication

The notification was signed by Kelash Bunkar, Wholetime Director with DIN 10911360, on April 1, 2026. The company has indicated that this information will also be made available on its official website at www.biogenpharma.bar for broader accessibility to stakeholders.

Company Information

Biogen Pharmachem Industries Limited operates from its registered office located at Shop No. 8, First Floor, Makers – 1 Building, Jawahar Road, Rajkot-360001. The company maintains communication through its official email biogenpharmachem@gmail.com and continues to fulfill its disclosure obligations as a listed entity.

Biogen Pharmachem Industries Limited has issued an official postal ballot notice for shareholder voting on major corporate actions, including a 1:6 bonus share issue and significant capital structure changes. The company has set a comprehensive voting timeline with the e-voting period scheduled from March 27 to April 25, 2026.

Postal Ballot Timeline and Process

The company has established a detailed calendar for the postal ballot process, with all key dates clearly defined for shareholder participation.

Event: Date & Time Cut-off Date: Friday, March 20, 2026 E-Voting Commencement: Friday, March 27, 2026 at 9:00 AM E-Voting Closure: Saturday, April 25, 2026 at 5:00 PM Scrutinizer Report Submission: On or before Monday, April 27, 2026 Result Declaration: On or before Monday, April 27, 2026

Bonus Share Issuance Details

The board has recommended issuing fully paid-up bonus shares in a 1:6 ratio, providing shareholders with 1 new equity share for every 6 existing shares held. The bonus issue will create approximately 15,04,33,833 new equity shares of Rs. 1 each, funded through the company's securities premium account.

Parameter: Details Bonus Ratio: 1:6 (1 share for every 6 held) New Shares: 15,04,33,833 equity shares Face Value: Rs. 1 per share Funding Source: Securities Premium Account Amount Required: Rs. 15,04,33,833 Available Premium: Rs. 17,00,00,000

Capital Structure Changes

The board approved increasing the company's authorized share capital substantially to accommodate future growth and the bonus issue.

Capital Structure: Pre-Bonus Post-Bonus Authorized Capital: Rs. 91,00,00,000 Rs. 1,08,00,00,000 Paid-up Capital: Rs. 90,26,03,000 Rs. 1,05,30,36,833 Number of Shares: 90,26,03,000 1,05,30,36,833

Statutory Auditor Appointment

The postal ballot includes approval for appointing M/s. Goenka Mehta & Associates Chartered Accountants, Rajkot as statutory auditors to fill the casual vacancy. M/s. Rishi Sekhri & Associates Chartered Accountants resigned from their position due to significant medical conditions, with the resignation taking effect from February 9, 2026.

Auditor Transition: Details Outgoing Auditor: M/s. Rishi Sekhri & Associates Resignation Date: February 9, 2026 Reason: Significant medical conditions New Auditor: M/s. Goenka Mehta & Associates Appointment Date: February 11, 2026 Location: Rajkot Firm Registration: 129445W

E-Voting Process and Shareholder Rights

The company will conduct the postal ballot exclusively through electronic voting via NSDL's e-voting platform. Shareholders whose names appear in the register of members or beneficial owners list as on the cut-off date of March 20, 2026, are eligible to participate in the voting process.

The voting covers three ordinary resolutions: approval for bonus share issue in 1:6 ratio, increase in authorized share capital from Rs. 91,00,00,000 to Rs. 1,08,00,00,000 with consequent alteration of Clause V of the Memorandum of Association, and appointment of statutory auditors.

Regulatory Compliance and Documentation

M/s. Daksha Negi & Associates, Practicing Company Secretaries, has been appointed as the scrutinizer for conducting the voting process. The company has ensured full compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and other applicable regulations.

The bonus shares, once allotted, will rank pari-passu with existing equity shares and carry identical rights. Shareholders will be entitled to participate in dividends and other corporate actions declared after the new shares are allotted. The company maintains adequate reserves with securities premium available totaling Rs. 17,00,00,000, providing sufficient coverage for the required Rs. 15,04,33,833 for bonus implementation.

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.

As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.

Recent News

Indian markets offer strong 'alpha' opportunities in FY27 despite Middle East risks: Report
Indian markets offer strong 'alpha' opportunities in FY27 de...
01 Apr 2026
Shrimay Enterprises Increases Stake in Pricol Limited to 2.14% Through Corporate Amalgamation
Shrimay Enterprises Increases Stake in Pricol Limited to 2.1...
01 Apr 2026
Online travel platform Travomint files confidential IPO papers with Sebi
Online travel platform Travomint files confidential IPO pape...
01 Apr 2026
Vivid Electromech IPO allotment date likely today. GMP, steps to check share allotment status online of SME IPO
Vivid Electromech IPO allotment date likely today. GMP, step...
01 Apr 2026
Kay Jay Forgings Files Draft Papers With Sebi For Rs 360
Kay Jay Forgings Files Draft Papers With Sebi For Rs 360
01 Apr 2026
Travomint Treads IPO Path Through Confidential Filings
Travomint Treads IPO Path Through Confidential Filings
01 Apr 2026
13 equity mutual funds lose over 15% in 6 months. Were they a part of your portfolio?
13 equity mutual funds lose over 15% in 6 months. Were they...
01 Apr 2026
Emiac Technologies IPO Dy 3: Issue booked 28% so far - Check price band, GMP, issue dates and other details about SME
Emiac Technologies IPO Dy 3: Issue booked 28% so far - Check...
01 Apr 2026
Amir Chand Jagdish Kumar IPO listing date tomorrow. Here’s what GMP signals ahead of stock market debut
Amir Chand Jagdish Kumar IPO listing date tomorrow. Here’s w...
01 Apr 2026
VCs bagged nearly $2 billion from 2025 IPO exits: Bain
VCs bagged nearly $2 billion from 2025 IPO exits: Bain
01 Apr 2026
pre ipo advisory services in India
  • GST No: 07AAHCB7068H2ZF

India IPO is a leading Indian business services platform that helps firms and companies to launch their initial public offerings (IPOs) in order to raise essential capital for growth and expansion while adding value & fueling the nation’s immense potential and future opportunities.

Follow us:

Facebook Twitter LinkedIn Instagram YouTube

Quick Links

  • Home
  • Blogs
  • Consultant
  • Youtube Videos
  • News
  • Contact Us
  • Career

Contact Information:

  • Corporate Office: 808, 8th Floor, D-Mall, Netaji Subhash Place, Pitampura, Delhi-110034
  • Regional Office: Office No. 601, Shagun Insignia, Ulwe, Sector-19, Navi Mumbai- 410206
  • Email: info@indiaipo.in
  • Mobile: +91-74283-37280, +91-96509-82781
  • Disclaimer  |
  • Privacy & Policy  |
  • Terms & Conditions  

Copyright © All rights reserved by - Bmarkt Tecamat Private Limited